Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Upcoming Events and Highlights
Investor News
Share Price / Index
December 17, 2024
Not intended for U.S. and UK Media
Aflibercept 8 mg met primary endpoint in phase III study and demonstrates vision gains with extended treatment intervals in retinal vein occlusion
December 13, 2024
Not intended for U.S. and UK Media
Acoramidis receives positive CHMP opinion for treatment of transthyretin amyloid cardiomyopathy
Discover More
